In December 2017, the FDA approved a new injectable drug to treat type 2 diabetes called semaglutide, which you likely know by its brand name: Ozempic. A few years later, during the pandemic, Wegovy, ...
Everyday Health on MSN
The risks of buying compounded GLP-1 drugs online
Custom formulations of popular weight loss medications have surged in popularity due to the high costs of FDA-approved drugs.
Shortages and big price tags have driven patients to unconventional sources of GLP-1 drugs In late 2022, pharmacist Joseph Lambson got an unusual call from a poison control specialist. He said, “Hey ...
GLP-1 medications like Ozempic have dominated headlines over the past couple of years. When writing his new book, Diet, Drugs and Dopamine: The New Science of Achieving a Healthy Weight, former FDA ...
The National Academies Forum on Drug Discovery, Development, and Translation convened this public workshop to examine the state of the science of drug regulation and consider approaches for enhancing ...
The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task ...
Name brand GLP-1 drugs like Ozempic and Wegovy have quickly become household names, akin to Tylenol or Advil, and their rise in popularity is only increasing. Originally developed to treat Type 2 ...
According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained ...
David Kessler took GLP-1 drugs to help manage his weight. In his new book, he explains why the drugs are revolutionary, but not a panacea. The following is an excerpt from Diet, Drugs, and Dopamine: ...
Hosted on MSN
Non-antibiotic drugs can also disrupt the microbiome
Non-antibiotic drugs can alter the microbiome and increase the risk of gut infections in surprising ways, a new Nature study shows. Subscribe to our newsletter for the latest sci-tech news updates.
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved. When you purchase through links on our site, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results